InvestorsHub Logo
Followers 2
Posts 331
Boards Moderated 0
Alias Born 09/13/2018

Re: cardvic post# 8765

Tuesday, 02/09/2021 2:33:58 AM

Tuesday, February 09, 2021 2:33:58 AM

Post# of 9237
Yes, even ACB that is already above Cronos costs much less. I don't trust Gorenstein's PR because they have historically collapsed the stock price. The big problem with Cronos is that it is still valued based on its production and sales capacity, and that has never really been Cronos' business. I think the only thing that can get this action to where it should be is the news from the laboratory and I think that until September we will not know anything. For those of us who have relied on Cron, times like these are disappointing to see couples as bad as ACB above. Even Aphria's valuation is still bad when you compare it to ACB. And that Cronos is below ACB seems incredible to me. It really shows that these are news stocks, and very young people, many of them reluctant to read and research, and consequently end up buying what the pack buys. On the other hand, have you noticed that there are no MF articles? I find it so strange that there is no "shorts" campaign at the moment ... my humble opinion, just that.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRON News